Jie Qing

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Cognitive Decline

Top Venues

ACS chemical biology

ACS pharmacology & translational science

Experimental biology and medicine (Maywood, N.J.)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Xue Yang, Yangying Ou, Ying Yang, Lu Wang, Yuwei Zhang, Fulan Zhao, Pixian Shui, Jie Qing
Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis. Experimental biology and medicine (Maywood, N.J.) (2023)
Yafeng Ren, Yuwei Zhang, Lu Wang, Fuqian He, Mengli Yan, Xiaoheng Liu, Yangying Ou, Qinkai Wu, Tao Bi, Shiyuan Wang, Jian Liu, Bi-Sen Ding, Li Wang, Jie Qing
Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis. ACS pharmacology & translational science 4 (3) (2021)
Mengjun Zheng, Wei Cong, Haoran Peng, Jie Qing, Huaxing Shen, Yaxin Tang, Chenchen Geng, Si Chen, Yan Zou, Wei-Dong Zhang, Hong-Gang Hu, Wuyuan Lu
Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor. Journal of medicinal chemistry 64 (23) (2021)
Jie Qing, Ming Wu, Rui Luo, Jizheng Chen, Lin Cao, Debin Zeng, Luqing Shang, Junxiu Nong, Qinkai Wu, Bi-Sen Ding, Xinwen Chen, Zihe Rao, Sanling Liu, Zhiyong Lou
Identification of Interferon Receptor IFNAR2 As a Novel HCV Entry Factor by Using Chemical Probes. ACS chemical biology 15 (5) (2020)